UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000040763
Receipt No. R000046549
Scientific Title Oncologic outcomes of laparoscopic surgery in complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer
Date of disclosure of the study information 2020/06/15
Last modified on 2020/06/16 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Oncologic outcomes of laparoscopic surgery in complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer
Acronym Oncologic outcome of Lap-CME with D3 for T3/T4a colorectal cancer
Scientific Title Oncologic outcomes of laparoscopic surgery in complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer
Scientific Title:Acronym Oncologic outcome of Lap-CME with D3 for T3/T4a colorectal cancer
Region
Japan

Condition
Condition Colorectal cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Oncologic outcome of Laparoscopic CME with D3
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 5-year-recurrence free survival
Key secondary outcomes 5-year overall survival

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >
Gender Male and Female
Key inclusion criteria T3/T4a colorectal cancer
R0 resection
Key exclusion criteria synchronous malignancies, emergency surgery, appendiceal tumor, familial tumor (familial adenomatous polyposis or lynch syndrome), inflammatory bowel disease,neuroendocrine tumor, and D2 lymph node dissection
Target sample size 1200

Research contact person
Name of lead principal investigator
1st name Tsuyoshi
Middle name
Last name Konishi
Organization Cancer Institute Hospital of the Japanese Foundation for Cancer Research
Division name Gastroenterological Surgery
Zip code 135-8550
Address 3-8-31 Ariake, Koto-ku, Tokyo, Japan
TEL +81-3-3520-0111
Email tkonishi-tky@umin.ac.jp

Public contact
Name of contact person
1st name Tsuyoshi
Middle name
Last name Konishi
Organization Cancer Institute Hospital of the Japanese Foundation for Cancer Research
Division name Gastroenterological Surgery
Zip code 135-8550
Address 3-8-31 Ariake, Koto-ku, Tokyo, Japan
TEL +81-3-3520-0111
Homepage URL
Email tetsuro.tominaga@nagasaki-u.ac.jp

Sponsor
Institute Cancer Institute Hospital of the Japanese Foundation for Cancer Research
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Cancer Institute Hospital of the Japanese Foundation for Cancer Research
Address 3-8-31 Ariake, Koto-ku, Tokyo, Japan
Tel +81-3-3520-0111
Email tetsuro.tominaga@nagasaki-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 1191
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 06 Month 01 Day
Date of IRB
2018 Year 07 Month 25 Day
Anticipated trial start date
2018 Year 08 Month 01 Day
Last follow-up date
2019 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information we aimed to examine the oncological safety of laparoscopic CME with D3 dissection for pT3/4a colon cancer, and to examine whether increased use of a laparoscopic approach changed the outcomes in a cohort at a comprehensive cancer center.

Management information
Registered date
2020 Year 06 Month 15 Day
Last modified on
2020 Year 06 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046549